Inherited Thrombocytopenia Due to GATA-1 Mutations

 

 Buy Article Permissions and Reprints

ABSTRACT

The GATA family of transcription factors, including the founding member, GATA-1, have an important role in gene regulation. GATA-1 is integral to successful hematopoiesis. A wide variety of mutations in GATA-1 affect its function, as well as its interaction with its cofactors (especially Friend of GATA) and the genes upon which GATA-1 acts. Here we review the known mutations, focusing on the specific alterations within the amino acid sequence, the resulting effect on hematopoietic development, and the clinical manifestations that result. Attention is also paid to the relationship between Trisomy 21, also known as Down syndrome, and the phenomenon of a truncated GATA-1, named GATA-1s. The evidence for specific interaction between GATA-1 and chromosome 21, which may explain the correlation between these two mutations, is briefly reviewed.

REFERENCES

• 1 Tsai S F, Martin D I, Zon L I, D'Andrea A D, Wong G G, Orkin S H. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.  Nature. 1989;  339 (6224) 446-451
  Google Scholar
• 2 Zon L I, Tsai S F, Burgess S, Matsudaira P, Bruns G A, Orkin S H. The major human erythroid DNA-binding protein (GF-1): primary sequence and localization of the gene to the X chromosome.  Proc Natl Acad Sci U S A. 1990;  87 (2) 668-672
  Google Scholar
• 3 Lowry J A, Mackay J P. GATA-1: one protein, many partners.  Int J Biochem Cell Biol. 2006;  38 (1) 6-11
  Google Scholar
• 4 Pevny L, Simon M C, Robertson E et al.. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.  Nature. 1991;  349 (6306) 257-260
  Google Scholar
• 5 Pevny L, Lin C S, D'Agati V, Simon M C, Orkin S H, Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1.  Development. 1995;  121 (1) 163-172
  Google Scholar
• 6 Fujiwara Y, Browne C P, Cunniff K, Goff S C, Orkin S H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1.  Proc Natl Acad Sci U S A. 1996;  93 (22) 12355-12358
  Google Scholar
• 7 Shivdasani R A, Fujiwara Y, McDevitt M A, Orkin S H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.  EMBO J. 1997;  16 (13) 3965-3973
  Google Scholar
• 8 Hirasawa R, Shimizu R, Takahashi S et al.. Essential and instructive roles of GATA factors in eosinophil development.  J Exp Med. 2002;  195 (11) 1379-1386
  Google Scholar
• 9 Migliaccio A R, Rana R A, Sanchez M et al.. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant.  J Exp Med. 2003;  197 (3) 281-296
  Google Scholar
• 10 Martin D I, Zon L I, Mutter G, Orkin S H. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages.  Nature. 1990;  344 (6265) 444-447
  Google Scholar
• 11 Wakabayashi J, Yomogida K, Nakajima O et al.. GATA-1 testis activation region is essential for Sertoli cell-specific expression of GATA-1 gene in transgenic mouse.  Genes Cells. 2003;  8 (7) 619-630
  Google Scholar
• 12 Balduini C L, Pecci A, Loffredo G et al.. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis.  Thromb Haemost. 2004;  91 (1) 129-140
  Google Scholar
• 13 Tsang A P, Fujiwara Y, Hom D B, Orkin S H. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG.  Genes Dev. 1998;  12 (8) 1176-1188
  Google Scholar
• 14 Ohneda K, Yamamoto M. Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage.  Acta Haematol. 2002;  108 (4) 237-245
  Google Scholar
• 15 Cantor A B. GATA transcription factors in hematologic disease.  Int J Hematol. 2005;  81 (5) 378-384
  Google Scholar
• 16 Vyas P, Ault K, Jackson C W, Orkin S H, Shivdasani R A. Consequences of GATA-1 deficiency in megakaryocytes and platelets.  Blood. 1999;  93 (9) 2867-2875
  Google Scholar
• 17 Tsang A P, Visvader J E, Turner C A et al.. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation.  Cell. 1997;  90 (1) 109-119
  Google Scholar
• 18 Chang A N, Cantor A B, Fujiwara Y et al.. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis.  Proc Natl Acad Sci U S A. 2002;  99 (14) 9237-9242
  Google Scholar
• 19 Zhu Q, Watanabe C, Liu T et al.. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.  Blood. 1997;  90 (7) 2680-2689
  Google Scholar
• 20 Mehaffey M G, Newton A L, Gandhi M J, Crossley M, Drachman J G. X-linked thrombocytopenia caused by a novel mutation of GATA-1.  Blood. 2001;  98 (9) 2681-2688
  Google Scholar
• 21 Nichols K E, Crispino J D, Poncz M et al.. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.  Nat Genet. 2000;  24 (3) 266-270
  Google Scholar
• 22 Freson K, Devriendt K, Matthijs G et al.. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.  Blood. 2001;  98 (1) 85-92
  Google Scholar
• 23 Freson K, Matthijs G, Thys C et al.. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.  Hum Mol Genet. 2002;  11 (2) 147-152
  Google Scholar
• 24 Ciovacco W A, Raskind W H, Kacena M A. Human phenotypes associated with GATA-1 mutations.  Gene. 2008;  427 (1-2) 1-6
  Google Scholar
• 25 Del Vecchio G C, Giordani L, De Santis A, De Mattia D. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.  Acta Haematol. 2005;  114 (2) 113-116
  Google Scholar
• 26 White J G. Platelet pathology in carriers of the X-linked GATA-1 macrothrombocytopenia.  Platelets. 2007;  18 (8) 620-627
  Google Scholar
• 27 White J G, Nichols W L, Steensma D P. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia II. Cytochemistry.  Platelets. 2007;  18 (6) 436-450
  Google Scholar
• 28 Raskind W H, Niakan K K, Wolff J et al.. Mapping of a syndrome of X-linked thrombocytopenia with Thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia.  Blood. 2000;  95 (7) 2262-2268
  Google Scholar
• 29 Hughan S C, Senis Y, Best D et al.. Selective impairment of platelet activation to collagen in the absence of GATA1.  Blood. 2005;  105 (11) 4369-4376
  Google Scholar
• 30 Tubman V N, Levine J E, Campagna D R et al.. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.  Blood. 2007;  109 (8) 3297-3299
  Google Scholar
• 31 Yu C, Niakan K K, Matsushita M, Stamatoyannopoulos G, Orkin S H, Raskind W H. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction.  Blood. 2002;  100 (6) 2040-2045
  Google Scholar
• 32 Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome.  Tohoku J Exp Med. 1984;  143 (3) 261-287
  Google Scholar
• 33 Salles I I, Feys H B, Iserbyt B F, De Meyer S F, Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function.  Blood Rev. 2008;  22 (3) 155-172
  Google Scholar
• 34 Clauser S, Cramer-Bordé E. Role of platelet electron microscopy in the diagnosis of platelet disorders.  Semin Thromb Hemost. 2009;  35 (2) 213-223
  Google Scholar
• 35 Gunay-Aygun M, Zivony-Elboum Y, Gumruk F et al.. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.  Blood. 2010;  116 (23) 4990-5001
  Google Scholar
• 36 Balduini C L, De Candia E, Savoia A. Why the disorder induced by GATA1 Arg216Gln mutation should be called “X-linked thrombocytopenia with thalassemia” rather than “X-linked gray platelet syndrome”.  Blood. 2007;  110 (7) 2770-2771 author reply 2771
  Google Scholar
• 37 Phillips J D, Steensma D P, Pulsipher M A, Spangrude G J, Kushner J P. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.  Blood. 2007;  109 (6) 2618-2621
  Google Scholar
• 38 Bishop D F, Schneider-Yin X, Clavero S, Yoo H W, Minder E I, Desnick R J. Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.  Blood. 2010;  115 (5) 1062-1069
  Google Scholar
• 39 Ged C, Moreau-Gaudry F, Richard E, Robert-Richard E, de Verneuil H. Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.  Cell Mol Biol (Noisy-le-grand). 2009;  55 (1) 53-60
  Google Scholar
• 40 Hindmarsh J T. The porphyrias: recent advances.  Clin Chem. 1986;  32 (7) 1255-1263
  Google Scholar
• 41 Hollanda L M, Lima C S, Cunha A F et al.. An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis.  Nat Genet. 2006;  38 (7) 807-812
  Google Scholar
• 42 Wechsler J, Greene M, McDevitt M A et al.. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.  Nat Genet. 2002;  32 (1) 148-152
  Google Scholar
• 43 Roy A, Roberts I, Norton A, Vyas P. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.  Br J Haematol. 2009;  147 (1) 3-12
  Google Scholar
• 44 Tigay J H. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.  J Pediatr Oncol Nurs. 2009;  26 (6) 362-368
  Google Scholar
• 45 Ahmed M, Sternberg A, Hall G et al.. Natural history of GATA1 mutations in Down syndrome.  Blood. 2004;  103 (7) 2480-2489
  Google Scholar
• 46 Crispino J D. GATA1 in normal and malignant hematopoiesis.  Semin Cell Dev Biol. 2005;  16 (1) 137-147
  Google Scholar
• 47 Crispino J D. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.  Pediatr Blood Cancer. 2005;  44 (1) 40-44
  Google Scholar
• 48 Creutzig U, Reinhardt D, Diekamp S, Dworzak M, Stary J, Zimmermann M. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.  Leukemia. 2005;  19 (8) 1355-1360
  Google Scholar
• 49 Waltzer L, Ferjoux G, Bataillé L, Haenlin M. Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis.  EMBO J. 2003;  22 (24) 6516-6525
  Google Scholar
• 50 Elagib K E, Racke F K, Mogass M, Khetawat R, Delehanty L L, Goldfarb A N. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.  Blood. 2003;  101 (11) 4333-4341
  Google Scholar

Melissa A KacenaPh.D. 

Assistant Professor, Department of Orthopaedic Surgery, Indiana University School of Medicine

1120 South Drive, FH 115, Indianapolis, IN 46202

Email: mkacena@iupui.edu